Michael W Rogers's Net Worth

$1.39 Million

Estimate Recalculated Sep 8, 2024 07:28PM EST

Who is Michael W Rogers?

Michael W Rogers has an estimated net worth of $1.39 Million. This is based on reported shares across multiple companies, which include BG Medicine, Inc., pSivida LTD, Aerpio Pharmaceuticals, Inc., CORONADO BIOSCIENCES INC, ACORDA THERAPEUTICS INC, Akebia Therapeutics, Inc., Aravive, Inc., KERYX BIOPHARMACEUTICALS INC, and INDEVUS PHARMACEUTICALS INC.

SEC CIK

Michael W Rogers's CIK is 0001244159

Past Insider Trading and Trends

2018 was Michael W Rogers's most active year for acquiring shares with 13 total transactions. Michael W Rogers's most active month to acquire stocks was the month of May. 2008 was Michael W Rogers's most active year for disposing of shares, totalling 5 transactions. Michael W Rogers's most active month to dispose stocks was the month of March. 2017 saw Michael W Rogers paying a total of $1,611,533.00 for 365,506 shares, this is the most they've acquired in one year. In 2014 Michael W Rogers cashed out on 5,930 shares for a total of $196,843.41, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BG Medicine, Inc. No price found

EVP, CFO and Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
—
—
0
Jun 30
Form 3
—
0
—
—
0
No matching records found

pSivida LTD (EYPT) Snapshot price: $7.97

Investor

Michael W Rogers owns 119,167 units of Common Stock which is worth $949,760.99.acquired a total of 119,167 shares in pSivida LTD at a cost of $113,000.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 25
Form 4
+5.93%
6.67K
—
—
119.17K
Jun 21
Form 4
+800.00%
100K
$1.13
$113,000.00
112.5K
Nov 15
Form 4
∞
12.5K
—
—
12.5K
Jun 27
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
—
—
0
Dec 12
Form 4
—
0
—
—
0
Dec 3
Form 4
—
0
—
—
0
Dec 11
Form 4
—
0
—
—
0
Dec 18
Form 4
—
0
—
—
0
Dec 14
Form 4
—
0
—
—
0
Nov 29
Form 4
—
0
—
—
0
Dec 9
Form 4
—
0
—
—
0
Nov 19
Form 4
—
0
—
—
0
Nov 18
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Nov 27
Form 3
—
0
—
—
0
No matching records found

Aerpio Pharmaceuticals, Inc. (AADI) Snapshot price: $1.82

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
Feb 15
Form 4
—
0
—
—
0
Apr 23
Form 4
—
0
—
—
0
Dec 14
Form 3
—
0
—
—
0
No matching records found

CORONADO BIOSCIENCES INC (FBIO) Snapshot price: $1.79

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 7
Form 4
—
0
—
—
0
Feb 10
Form 3
—
0
—
—
0
No matching records found

ACORDA THERAPEUTICS INC (ACOR) No price found

Chief Financial Officer

Michael W Rogers owns 40,713 units of Common Stock. In the year 2013 Michael W Rogers filed a total of 11 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 11
Form 4
—
0
—
—
0
Mar 2
Form 4
-2.31%
-964.00
$38.06
-$36,689.17
40.71K
Scheduled
Dec 1
Form 4
-12.03%
-5.70K
$30.24
-$172,359.39
41.68K
Scheduled
Oct 7
Form 4
+14.15%
5.87K
—
—
47.38K
Mar 4
Form 4
—
0
—
—
0
Dec 29
Form 4
-0.55%
-230.00
$35.58
-$8,183.10
41.51K
Scheduled
Dec 1
Form 4
-12.02%
-5.70K
$33.10
-$188,660.31
41.73K
Scheduled
Oct 7
Form 4
+4.02%
1.83K
—
—
47.44K
Mar 5
Form 4
∞
45.6K
—
—
45.6K
Oct 7
Form 3
—
0
—
—
0
No matching records found